.Merck defeats revenues desires, brings up purchases outlook on powerful need for leading medicines like Keytruda CNBCMerck & Co. (MRK United States) Beats Income Estimates as Keytruda Sales Increase BloombergMerck Stock: Pharma Giant Posts Powerful End Results, But Overview Drops Short Investor's Company DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats profit as well as purchases requirements amid Keytruda strong point, yet offers combined full-year outlook MarketWatch.